HK6190A - Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivatives - Google Patents
Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivativesInfo
- Publication number
- HK6190A HK6190A HK61/90A HK6190A HK6190A HK 6190 A HK6190 A HK 6190A HK 61/90 A HK61/90 A HK 61/90A HK 6190 A HK6190 A HK 6190A HK 6190 A HK6190 A HK 6190A
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydroxypyrid
- derivatives
- substituted
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8208608 | 1982-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK6190A true HK6190A (en) | 1990-02-02 |
Family
ID=10529232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK61/90A HK6190A (en) | 1982-03-24 | 1990-01-25 | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivatives |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4840958A (fr) |
| EP (1) | EP0093498B1 (fr) |
| JP (3) | JPS58174319A (fr) |
| CY (1) | CY1502A (fr) |
| DE (2) | DE3367849D1 (fr) |
| GR (1) | GR78491B (fr) |
| HK (1) | HK6190A (fr) |
| NL (1) | NL990031I2 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| EP0305646B1 (fr) * | 1983-03-24 | 1996-11-13 | Btg International Limited | 3-Hydroxypyrid-ones et compositions pharmaceutiques |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325494D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| EP0335745A1 (fr) * | 1988-03-31 | 1989-10-04 | The Royal Free Hospital School Of Medicine | Procédé de préparation de pyridin-4-ones |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| ES2230564T3 (es) | 1995-06-10 | 2005-05-01 | Vitra Pharmaceuticals Ltd. | Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds. |
| US6004986A (en) * | 1997-05-08 | 1999-12-21 | The University Of Virginia Patent Foundation | Method for treating cerebral vasospasm and cerebral ischemia using iron chelators and pharmaceutical compositions therefor |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| IL135884A (en) * | 2000-04-30 | 2005-08-31 | Yissum Res Dev Co | Method for measuring non-transferrin bound iron |
| ES2236300T3 (es) * | 2000-09-19 | 2005-07-16 | Vitra Pharmaceuticals Ltd. | Composiciones de hierro. |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| EP2295980A1 (fr) | 2002-10-30 | 2011-03-16 | Yissum Research Development Company, of The Hebrew University of Jerusalem | Molécules et leurs procédés d'utilisation pour la mesure de fer non lié par la transferrine |
| EP1565185A4 (fr) | 2002-11-07 | 2011-01-05 | Technion Res & Dev Foundation | Chelateurs du fer et compositions pharmaceutiques les renfermant |
| CA2488034C (fr) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Procede de production de 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide et d'analogues |
| EP2542077A4 (fr) * | 2010-03-04 | 2013-08-21 | Merck Sharp & Dohme | Inhibiteurs de catéchol o-méthyl transférase et utilisation associée dans le traitement de troubles psychotiques |
| GB201007209D0 (en) | 2010-04-29 | 2010-06-16 | King S College London | Compound |
| WO2012137202A1 (fr) | 2011-04-05 | 2012-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci) |
| CN116751200A (zh) | 2016-11-07 | 2023-09-15 | 爱彼特生物制药公司 | 含有取代的吡啶酮的三环化合物以及使用其的方法 |
| US11702427B2 (en) | 2018-03-12 | 2023-07-18 | Arbutus Biopharma Corporation | Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same |
| US11505551B2 (en) | 2018-04-12 | 2022-11-22 | Arbutus Biopharma Corporation | Methods for preparing substituted pyridinone-containing tricyclic compounds |
-
1983
- 1983-03-23 GR GR70868A patent/GR78491B/el unknown
- 1983-03-24 DE DE8383301659T patent/DE3367849D1/de not_active Expired
- 1983-03-24 JP JP58049677A patent/JPS58174319A/ja active Granted
- 1983-03-24 DE DE1999175062 patent/DE19975062I1/de active Pending
- 1983-03-24 CY CY1502A patent/CY1502A/xx unknown
- 1983-03-24 JP JP58049676A patent/JPS58174318A/ja active Granted
- 1983-03-24 EP EP83301659A patent/EP0093498B1/fr not_active Expired
-
1986
- 1986-11-20 US US06/933,338 patent/US4840958A/en not_active Expired - Lifetime
-
1990
- 1990-01-25 HK HK61/90A patent/HK6190A/xx not_active IP Right Cessation
-
1992
- 1992-02-18 JP JP4030887A patent/JPH0757749B2/ja not_active Expired - Lifetime
-
1999
- 1999-10-06 NL NL990031C patent/NL990031I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0093498B1 (fr) | 1986-11-26 |
| NL990031I1 (nl) | 1999-12-01 |
| CY1502A (en) | 1990-08-03 |
| JPH0757749B2 (ja) | 1995-06-21 |
| GR78491B (fr) | 1984-09-27 |
| NL990031I2 (nl) | 2000-04-03 |
| JPS58174318A (ja) | 1983-10-13 |
| JPH0515693B2 (fr) | 1993-03-02 |
| DE3367849D1 (en) | 1987-01-15 |
| JPH0680636A (ja) | 1994-03-22 |
| JPH0460987B2 (fr) | 1992-09-29 |
| EP0093498A3 (en) | 1984-07-11 |
| DE19975062I1 (de) | 2003-09-04 |
| JPS58174319A (ja) | 1983-10-13 |
| EP0093498A2 (fr) | 1983-11-09 |
| US4840958A (en) | 1989-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3367849D1 (en) | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives | |
| GB8326565D0 (en) | Pharmaceutical compositions | |
| GB8327612D0 (en) | Pharmaceutical compositions | |
| CY1574A (en) | Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives | |
| ZA833781B (en) | Pharmaceutical compositions | |
| EP0093551A3 (en) | Pharmaceutical composition | |
| GB2118176B (en) | Pharmaceutical compositions | |
| GB2117766B (en) | Pharmaceutical compositions | |
| ZA836703B (en) | Pharmaceutical compositions | |
| GB8429749D0 (en) | Pharmaceutical compositions | |
| GB8313814D0 (en) | Pharmaceutical compositions | |
| IL69294A0 (en) | Pharmaceutical compositions containing sugar derivatives | |
| GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
| DE3377696D1 (en) | Pharmaceutical compositions | |
| US4594359B1 (en) | Pharmaceutical compositions | |
| GB8328896D0 (en) | Pharmaceutical composition | |
| GB2114001B (en) | Nasel pharmaceutical compositions | |
| IL67881A0 (en) | Pharmaceutical compositions including certain cholecalciferol derivatives | |
| GB8305028D0 (en) | Pharmaceutical compositions | |
| GB8314736D0 (en) | Pharmaceutical compositions | |
| GB8330810D0 (en) | Pharmaceutical compositions | |
| GB8331068D0 (en) | Pharmaceutical compositions | |
| GB8329391D0 (en) | Pharmaceutical compositions | |
| GB8314540D0 (en) | Pharmaceutical composition | |
| DE3372706D1 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |